消化性溃疡治疗市场：按产品类型、按适应症、按分销渠道、按地区-规模、份额、展望、机会分析，2023-2030年

消化性溃疡是在胃和小肠上部形成的开放性溃疡。 消化性溃疡最常见的症状是胃痛。 消化性溃疡包括：胃内部形成的胃溃疡和小肠上部（十二指肠）内部形成的十二指肠溃疡。 消化性溃疡最常见的原因是幽门螺桿菌（H. pylori）感染和长期使用非甾体类抗炎药（NSAID），如布洛芬（Advil、Motrin IB等）和□普生钠（Aleb）压力和辛辣食物不会引起消化性溃疡。 然而，它会使症状恶化。

消化性溃疡最常见的症状是胃灼痛。 胃酸会使疼痛加剧，空腹也会加剧疼痛。 消化性溃疡是胃或小肠第一部分的开放性溃疡。 大多数消化性溃疡是在消化系统的保护膜受到细菌感染损害时发生的。 经常服用止痛药的人更容易患溃疡。

市场动态

监管机构产品批准的增加预计将在预测期内推动市场增长。 例如，2021年12月，製药公司Edenbridge Pharmaceuticals宣布，美国食品药品监督管理局已批准格隆溴铵口腔崩解片作为缓解和治疗消化性溃疡症状的辅助药物。

本研究的主要特点

• 本报告对全球消化性溃疡药物市场进行了深入分析，并预测了以 2022 年为基准年的预测期内（2023-2030 年）的市场规模和復合年增长率 (CAGR%)。 。
• 它揭示了各个细分市场的潜在收入机会，并描述了该市场有吸引力的投资主张矩阵。
• 它还提供了有关市场促进因素、抑制因素、机遇、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
• 它根据以下参数（公司亮点、产品组合、主要亮点、财务业绩和战略）介绍了全球消化性溃疡治疗市场的主要参与者。
• 本研究涵盖的主要公司包括Daewoong Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd., Pfizer Inc., AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, GlaxoSmithKline plc.。
• 从本报告中获得的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。 .
• 《全球消化性溃疡治疗市场报告》面向该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
• 利益相关者可以通过用于分析全球消化性溃疡药物市场的各种策略矩阵来促进决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写

第 2 章市场展望

• 报告概述
  • 市场定义和范围
• 执行摘要
• 连贯的机会地图 (COM)

第 3 章市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 市场机会
• 影响分析
• 最近的产品公告
• 流行病学
• 合併、收购、联合研究
• 监管场景
• 主要进展
• PEST分析
• 管道分析

第 4 章全球消化性溃疡治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 经济影响
• COVID-19 的流行病学特征
• 对供需的影响

第 5 章全球消化性溃疡治疗市场：按产品类型划分，2017-2030

• 质子泵抑製剂
• 钾竞争性酸阻滞剂 (P-CAB)
• 抗酸剂
• H2-拮抗剂
• 抗生素
• 溃疡保护剂

第 6 章消化性溃疡药物的全球市场：疾病适应症，2017-2030

• 胃炎
• 胃溃疡
• 十二指肠溃疡
• 胃食管反流病 (GERD)

第 7 章消化性溃疡药物的全球市场：按分销渠道划分，2017-2030 年

• 医院药房
• 零售药店
• 网上药店

第 8 章消化性溃疡药物的全球市场：按地区划分，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 亚太地区其他地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第 9 章竞争格局

• Daewoong Pharmaceutical Co., Ltd.
• Takeda Pharmaceutical Co., Ltd.
• Pfizer Inc.
• AstraZeneca plc.
• RedHill Biopharma
• Cadila Healthcare Ltd.
• Novitium Pharma LLC.
• Boehringer Ingelheim GmbH
• Eisai Co. Ltd.
• Yuhan Corporation
• GlaxoSmithKline plc.

第 10 章

• 调查方法
• 关于出版商

Peptic ulcers are open sores that develop on the inside lining of your stomach and the upper portion of your small intestine. The most common symptom of a peptic ulcer is stomach pain. Peptic ulcers include: Gastric ulcers that occur on the inside of the stomach and Duodenal ulcers that occur on the inside of the upper portion of your small intestine (duodenum). The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve). Stress and spicy foods do not cause peptic ulcers. However, they can make your symptoms worse.

The most common peptic ulcer symptom is burning stomach pain. Stomach acid makes the pain worse, as does having an empty stomach. Peptic ulcer disease occurs when open sores, or ulcers, form in the stomach or first part of the small intestine. Many cases of peptic ulcer disease develop because a bacterial infection eats away the protective lining of the digestive system. People who frequently take pain relievers are more likely to develop ulcers.

Market Dynamics

An increase in product approval from the regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, in December 2021, Edenbridge Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration have approved glycopyrrolate orally disintegrating tablets to reduce the symptoms of a peptic ulcer and as an adjunct to treatment of peptic ulcers.

Key features of the study:

• This report provides an in-depth analysis of the global peptic ulcer drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global peptic ulcer drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Daewoong Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd., Pfizer Inc., AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, GlaxoSmithKline plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global peptic ulcer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptic ulcer drugs market

Detailed Segmentation:

• Global Peptic Ulcer Drugs Market, By Product Type:
  • Proton Pump Inhibitors
  • Potassium-Competitive Acid Blocker (P-CAB)
  • Antacids
  • H2- Antagonist
  • Antibiotics
  • Ulcer Protective
• Global Peptic Ulcer Drugs Market, By Disease Indication:
  • Gastitis
  • Gastric Ulcer
  • Duodenal Ulcer
  • Gastroesophageal Reflux Disease (GERD)
• Global Peptic Ulcer Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Peptic Ulcer Drugs Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Daewoong Pharmaceutical Co., Ltd *
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • AstraZeneca plc.
  • RedHill Biopharma
  • Cadila Healthcare Ltd.
  • Novitium Pharma LLC.
  • Boehringer Ingelheim GmbH
  • Eisai Co. Ltd.
  • Yuhan Corporation
  • GlaxoSmithKline plc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis
• Pipeline Analysis

4. Global Peptic Ulcer Drugs Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Peptic Ulcer Drugs Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Proton Pump Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Potassium-Competitive Acid Blocker (P-CAB)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Antacids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• H2- Antagonists
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Ulcer Protective
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Peptic Ulcer Drugs Market, By Disease Indication, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Gastitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gastric Ulcer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Duodenal Ulcer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gastroesophageal Reflux Disease (GERD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Peptic Ulcer Drugs Market, By Region, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Daewoong Pharmaceutical Co., Ltd.*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Takeda Pharmaceutical Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• AstraZeneca plc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• RedHill Biopharma
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Cadila Healthcare Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Novitium Pharma LLC.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Boehringer Ingelheim GmbH
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Eisai Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Yuhan Corporation
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• GlaxoSmithKline plc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

10. Section

• Research Methodology
• About Us